재고 위치

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

rhPTH (1-30) Impurity

● 재고 있음

카탈로그 번호:	VE0024055
CAS 번호:	N/A
분자식:	C157H260N48O46S2
분자량:	3620.2 g/mol

견적 요청

RFQ 목록에 추가

에 대한 추가 정보 rhPTH (1-30) Impurity

모약물

Teriparatide

IUPAC명

N/A

약전 동의어

N/A

Other Synonyms

N/A

SMILES

[H]N[C@@H](CO)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CCC(O)=O)C(N[C@]([C@H](CC)C)([H])C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@H](C(O)=O)CC(O)=O)=O)=O)=O)=O)=O)=O)=O)CC1=CNC2=C1C=CC=C2)=O)=O)=O)=O)=O)CCSC)=O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)=O)CC4=CN=CN4)=O)CCSC)=O)=O)=O)=O)=O)=O)=O

InChI

InChI=1S/C157H260N48O46S2/c1-19-83(16)126(205-140(235)99(41-46-122(218)219)185-151(246)114(73-208)202-153(248)124(81(12)13)203-127(222)88(161)71-206)154(249)189-96(38-43-116(163)210)134(229)192-104(58-78(6)7)143(238)186-101(48-55-253-18)138(233)197-109(63-86-69-171-75-177-86)147(242)199-110(64-117(164)211)148(243)190-102(56-76(2)3)128(223)175-70-119(213)178-90(32-22-25-49-158)129(224)196-108(62-85-68-170-74-176-85)146(241)194-106(60-80(10)11)144(239)198-111(65-118(165)212)149(244)201-113(72-207)150(245)187-100(47-54-252-17)137(232)183-97(39-44-120(214)215)133(228)181-94(36-29-53-173-157(168)169)139(234)204-125(82(14)15)152(247)188-98(40-45-121(216)217)135(230)195-107(61-84-67-174-89-31-21-20-30-87(84)89)145(240)193-105(59-79(8)9)141(236)182-93(35-28-52-172-156(166)167)131(226)179-91(33-23-26-50-159)130(225)180-92(34-24-27-51-160)132(227)191-103(57-77(4)5)142(237)184-95(37-42-115(162)209)136(231)200-112(155(250)251)66-123(220)221/h20-21, 30-31, 67-69, 74-83, 88, 90-114, 124-126, 174, 206-208H, 19, 22-29, 32-66, 70-73, 158-161H2, 1-18H3, (H2, 162, 209)(H2, 163, 210)(H2, 164, 211)(H2, 165, 212)(H, 170, 176)(H, 171, 177)(H, 175, 223)(H, 178, 213)(H, 179, 226)(H, 180, 225)(H, 181, 228)(H, 182, 236)(H, 183, 232)(H, 184, 237)(H, 185, 246)(H, 186, 238)(H, 187, 245)(H, 188, 247)(H, 189, 249)(H, 190, 243)(H, 191, 227)(H, 192, 229)(H, 193, 240)(H, 194, 241)(H, 195, 230)(H, 196, 224)(H, 197, 233)(H, 198, 239)(H, 199, 242)(H, 200, 231)(H, 201, 244)(H, 202, 248)(H, 203, 222)(H, 204, 234)(H, 205, 235)(H, 214, 215)(H, 216, 217)(H, 218, 219)(H, 220, 221)(H, 250, 251)(H4, 166, 167, 172)(H4, 168, 169, 173)/t83-, 88-, 90-, 91-, 92-, 93-, 94-, 95-, 96-, 97-, 98-, 99-, 100-, 101-, 102-, 103-, 104-, 105-, 106-, 107-, 108-, 109-, 110-, 111-, 112-, 113-, 114-, 124-, 125-, 126-/m0/s1

설명

The rhPTH (1-30) Impurity standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Teriparatide. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes.